Iambic Therapeutics IAM
NASDAQ IAM
$14.67 -0.72 (-4.64%)
As of: Nov 12, 2026 · 1:18 PM EST

Iambic Therapeutics (IAM) Property, Plant & Equipment (Net) (2024 - 2026)

Analysis

Iambic Therapeutics (IAM) Property, Plant & Equipment (Net) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 32.19 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 5.94 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 25.90 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 14.06 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 8.88 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 5.95 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 19.05 Bn
10 Iambic Therapeutics 63.00 Mn -144.88 Mn - 6.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.48 Mn
Dec 31, 2025 4.83 Mn
Dec 31, 2024 4.81 Mn
API Access

Iambic Therapeutics Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=IAM&period=max&api_key=YOUR_API_KEY